Jeffrey Lawson MD, PhD Appointed Chief Surgical Officer and Vice Chairman, to Enhance Product Positioning and Clinical Adoption Business Wire DURHAM, N.C. -- November 20, 2020 Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Laura Niklason MD, PhD has been...
DURHAM, N.C., Oct. 9, 2020 /PRNewswire/ -- A new manuscript published in the highly cited scientific journal Science (also known as Science Magazine ) reveals great strides in the field of regenerative medicine and vascular tissue engineering. Humacyte, Inc....
Honor Recognizes Humacyte’s Progress in Accelerating the Manufacturing Platform and Process for Producing Vascular Conduits for Hemodialysis and Vascular Trauma Business Wire DURHAM, N.C. -- April 8, 2019 Humacyte, an innovator in biotechnology and regenerative medicine, received the Medical...
RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Humacyte , an innovator in biotechnology and regenerative medicine, announced publication in the medical journal Science Translational Medicine, of pivotal scientific work demonstrating Humacyte’s human acellular vessels (HAVs) repopulate with the...
RESEARCH TRIANGLE PARK, N.C. – January 7, 2019. Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 37th Annual J.P....
